Lipid Metabolism
A section of Metabolites (ISSN 2218-1989).
Section Information
Aims
The “Lipid Metabolism” section accepts manuscripts of original research and high-quality reviews on all aspects of lipid metabolism, including lipoproteins, with a particular focus on biomarkers of risk. This section accepts research papers on the clinical significance of plasma lipid and lipoprotein alterations in acute and chronic diseases, including obesity, diabetes, and cardiovascular disease, with special interest regarding alterations related to cardiometabolic risk. In addition, research papers on the therapeutic modulation of plasma lipids and lipoproteins, including the role of lifestyle, nutraceuticals, and drugs, are also welcome, with novel therapeutic approaches being of particular interest. Finally, this section welcomes the submission of International Consensus Documents.
Scope
Topics of interest include, but are not limited to:
- Identification of novel risk biomarkers
- The clinical significance of plasma lipid and lipoprotein alterations
- The evaluation of novel biomarkers in acute and chronic diseases
- The role of lifestyle and nutraceuticals
- The role of novel therapeutic approaches in treating metabolic disease
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Lipid Metabolism Disorders in Obesity (Deadline: 10 July 2025)
- Psoriasis and Metabolic Syndrome (Deadline: 15 July 2025)
- Lipid Biomarkers and Cardiometabolic Diseases—2nd Edition (Deadline: 15 July 2025)
- Lipid Metabolism in Age-Related Diseases (Deadline: 31 July 2025)
- Lipidomic Signatures in Pediatric Metabolic Disorders (Deadline: 30 September 2025)
- Lipid Metabolism Dysregulation in Metabolic Disorders: Unraveling the Molecular Complexity (Deadline: 31 October 2025)
- Interplay Between Metabolism, Oxidative Stress, and Cellular Signaling in Health and Disease (Deadline: 30 November 2025)
- Lipid Signaling, Therapeutics and Controlled-Release (Deadline: 31 December 2025)
- MicroRNAs in Lipid Metabolism (Deadline: 31 December 2025)
- Metabolic Syndrome and Non-Alcoholic Liver Disease—Second Edition (Deadline: 31 January 2026)
